Literature DB >> 27438225

A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility.

Nerea Bilbao-Aldaiturriaga1, Ziortza Askaiturrieta1, Itsasne Granado-Tajada1, Katja Goričar2, Vita Dolžan2, Purificación Garcia-Miguel3, Nagore Garcia de Andoin4, Idoia Martin-Guerrero1, Africa Garcia-Orad1,5.   

Abstract

Two polymorphisms in the murine double minute 2 (MDM2) gene (rs1690916 and rs2279744) have been associated with the risk of osteosarcoma (OS). When we analyzed these two polymorphisms in two new independents cohorts (Spanish and Slovenian), we found no association. In order to clarify this, we conducted a meta-analysis including six populations, with a total of 246 OS patients and 1,760 controls for rs1690916; and 433 OS patients and 1,959 controls for rs2279744. Pooled odds ratio risks and corresponding 95% CI were estimated to assess the possible associations. Our results showed that these two polymorphisms were not associated with the susceptibility of OS under any genetic model studied. In conclusion, the present meta-analysis indicates that MDM2 rs1690916 and rs2279744 cannot be considered as genetic risk factors for OS susceptibility in the different populations. Therefore, the influence of these two polymorphisms on the risk of OS may be less important than previously suggested. Future studies are needed to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27438225     DOI: 10.1038/pr.2016.120

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

Review 1.  Primary malignant bone tumors--recent developments.

Authors:  Meera Hameed; Howard Dorfman
Journal:  Semin Diagn Pathol       Date:  2011-02       Impact factor: 3.464

2.  Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.

Authors:  Moriko Ito; Louise Barys; Terence O'Reilly; Sophie Young; Bella Gorbatcheva; John Monahan; Sabine Zumstein-Mecker; Peter F Choong; Ian Dickinson; Philip Crowe; Christine Hemmings; Jayesh Desai; David M Thomas; Joanna Lisztwan
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

Review 3.  Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.

Authors:  Domagoj Vucic; Vishva M Dixit; Ingrid E Wertz
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-23       Impact factor: 94.444

4.  Germ-line genetic variation of TP53 in osteosarcoma.

Authors:  Sharon A Savage; Laura Burdett; Rebecca Troisi; Chester Douglass; Robert N Hoover; Stephen J Chanock
Journal:  Pediatr Blood Cancer       Date:  2007-07       Impact factor: 3.167

5.  Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese.

Authors:  Jinshan He; Jingcheng Wang; Daxin Wang; Shanhe Dai; Tangyun Yv; Pengtao Chen; Renshi Ma; Chunyv Diao; Guohua Lv
Journal:  Endocr J       Date:  2013-08-09       Impact factor: 2.349

6.  Association of FGFR3 and MDM2 gene nucleotide polymorphisms with bone tumors.

Authors:  V A Naumov; E V Generozov; Yu N Solovyov; M D Aliev; N E Kushlinsky
Journal:  Bull Exp Biol Med       Date:  2012-10       Impact factor: 0.804

7.  Association of two polymorphisms rs2910164 in miRNA-146a and rs3746444 in miRNA-499 with rheumatoid arthritis: a meta-analysis.

Authors:  Ke Li; Hongtao Tie; Ning Hu; Hong Chen; Xinru Yin; Chao Peng; Jingyuan Wan; Wei Huang
Journal:  Hum Immunol       Date:  2014-05-10       Impact factor: 2.850

8.  A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma.

Authors:  Lisa Mirabello; Kai Yu; Sonja I Berndt; Laurie Burdett; Zhaoming Wang; Salma Chowdhury; Kedest Teshome; Arinze Uzoka; Amy Hutchinson; Tom Grotmol; Chester Douglass; Richard B Hayes; Robert N Hoover; Sharon A Savage
Journal:  BMC Cancer       Date:  2011-05-29       Impact factor: 4.430

9.  A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies.

Authors:  Jing Guo; Mingjuan Jin; Mingwu Zhang; Kun Chen
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

10.  MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.

Authors:  Stian Knappskog; Per E Lønning
Journal:  Oncotarget       Date:  2011-03
View more
  7 in total

1.  NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression.

Authors:  Qizhi Qin; Mario Gomez-Salazar; Robert J Tower; Leslie Chang; Carol D Morris; Edward F McCarthy; Kang Ting; Xinli Zhang; Aaron W James
Journal:  Cancer Res       Date:  2022-08-03       Impact factor: 13.312

Review 2.  Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact.

Authors:  Claudia Maria Hattinger; Maria Pia Patrizio; Silvia Luppi; Massimo Serra
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 3.  Systematic meta-analysis of genetic variants associated with osteosarcoma susceptibility.

Authors:  Xinjia Wang; Zhenyu Liu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

4.  Association between MDM2 rs2279744, MDM2 rs937283, and p21 rs1801270 polymorphisms and retinoblastoma susceptibility.

Authors:  Qixin Cao; Yun Wang; Xiaohui Song; Weihua Yang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

5.  Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis.

Authors:  Clara Benna; Andrea Simioni; Sandro Pasquali; Davide De Boni; Senthilkumar Rajendran; Giovanna Spiro; Chiara Colombo; Calogero Virgone; Steven G DuBois; Alessandro Gronchi; Carlo Riccardo Rossi; Simone Mocellin
Journal:  Oncotarget       Date:  2018-04-06

6.  Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.

Authors:  Fengsong Liu; Kai Wang; Liang Zhang; Ya-Lin Yang
Journal:  Oncol Lett       Date:  2018-08-06       Impact factor: 2.967

7.  The effects of common variants in MDM2 and GNRH2 genes on the risk and survival of osteosarcoma in Han populations from Northwest China.

Authors:  Weilou Feng; Zhi Wang; Dongxu Feng; Yangjun Zhu; Kun Zhang; Wei Huang
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.